Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review

Introduction Patients with translocation renal cell carcinoma (tRCC) have a poor prognosis without standardized treatment. Case presentation The first case was of a 72‐year‐old woman who underwent robot‐assisted partial nephrectomy for a left renal tumor and was pathologically diagnosed with tRCC. R...

Full description

Bibliographic Details

Published in:	IJU Case Reports
Main Authors:	Kenta Takahashi, Renpei Kato, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takaya Abe, Wataru Obara
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Subjects:	avelumab axitinib immune checkpoint inhibitors renal cell carcinoma translocation renal cell carcinoma
Online Access:	https://doi.org/10.1002/iju5.12685